Lucintel Forecasts the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market to Reach $13.0 billion by 2030
Lucintel Forecasts the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market to Reach $13.0 billion by 2030
Blog Article
According to a market report by Lucintel, the future of the global autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the applications. The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030 from $7.3 billion in 2024, at a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.
A more than 150-page report to understand trends, opportunity and forecast in autologous stem cell and non-stem cell based therapy market to 2030 by product type (blood pressure monitoring devices, pulmonary pressure monitoring devices, and intracranial pressure monitoring devices), type (autologous stem cells and autologous non-stem cells), application (neurodegenerative disorders, autoimmune diseases, cancer & tumors, and cardiovascular diseases), end use (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.
Download sample by clicking on autologous stem cell and non-stem cell based therapy market
North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.
BrainStorm Cell, Cytori Therapeutics, Dendreon Pharmaceuticals, Novartis, U.S. Stem Cell are the major suppliers in the autologous stem cell and non-stem cell based therapy market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Content Intelligence Market
Emergency Beacon Transmitter Market
Explainable AI Market
Fast Charging Protocol Chips Market
Hand-Held Stroboscope Market
Smart Guard Tour System Market